Edgestream Partners’s CareDx CDNA Stock Holding History

Edgestream Partners’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-34,012	Closed	-$728K	–	863
2024 Q4	$728K	Buy	+34,012	New	+$827K	0.03%	624

Other funds holding CDNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

OAM

Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Edgestream Partners's CDNA Position: Q1 2025 in Review

Edgestream Partners sold out of CareDx (CDNA) in Q1 2025, closing a stake of 34,012 shares — an estimated $728K sold.

Edgestream Partners first reported a position in CDNA in Q4 2024 and held it in 1 quarter. The position peaked at $728K in Q4 2024. 218 funds tracked by Wall St. Rank hold CDNA as of Q1 2025.

Edgestream Partners reported no remaining CareDx position as of Q1 2025 after selling out during the quarter.
Edgestream Partners sold 34,012 CareDx shares in Q1 2025, an estimated $728K.
Edgestream Partners first reported a position in CareDx in Q4 2024 and held it in 1 quarter.
Edgestream Partners's CareDx position peaked at $728K in Q4 2024.
218 funds tracked by Wall St. Rank held CareDx as of Q1 2025.

Based on Edgestream Partners's 13F filing for Q1 2025, filed 2 May 2025.